| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 38.672 | 96.789 | 138.016 | 233.310 | 141.091 | 60.017 | 351.768 | 495.167 | 234.171 |
| Total Income - EUR | - | 38.672 | 96.789 | 138.016 | 233.310 | 144.332 | 60.017 | 351.821 | 528.173 | 288.140 |
| Total Expenses - EUR | - | 517 | 10.785 | 18.639 | 32.805 | 50.046 | 32.993 | 86.471 | 252.852 | 246.282 |
| Gross Profit/Loss - EUR | - | 38.155 | 86.005 | 119.378 | 200.505 | 94.286 | 27.024 | 265.350 | 275.321 | 41.858 |
| Net Profit/Loss - EUR | - | 36.995 | 83.694 | 117.997 | 198.324 | 93.270 | 25.586 | 260.505 | 271.728 | 33.274 |
| Employees | - | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Dr. Mazilu & Co Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10 | 892 | 1.539 | 68.753 | 91.630 | 71.007 | 73.933 | 195.090 | 475.254 |
| Current Assets | - | 37.278 | 161.606 | 172.460 | 203.485 | 162.484 | 154.083 | 252.244 | 346.714 | 373.293 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 8.477 | 18.618 | 51.528 | 249.714 |
| Receivables | - | 0 | 35.026 | 72.395 | 150.266 | 135.376 | 131.837 | 126.926 | 24.889 | 64.053 |
| Cash | - | 37.278 | 126.580 | 100.065 | 53.219 | 27.107 | 13.770 | 106.700 | 270.297 | 59.525 |
| Shareholders Funds | - | 37.040 | 83.747 | 118.049 | 198.374 | 179.424 | 179.060 | 260.553 | 367.737 | 293.413 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 248 | 78.752 | 55.950 | 73.864 | 74.727 | 46.031 | 65.624 | 179.121 | 383.136 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 171.998 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Mazilu & Co Srl